NP207_66h: CD8b+/CD44-/CD45.1/+CD45.2+ naive T cells bearing the NP207 TCR
source_name
C57BL/6NTac
cell line
C57BL/6NTac
cell type
naive CD8+ T cells
genotype
retrogenic NP207 TCR
treatment
developed in vivo, cultured in vitro
geo_loc_name
missing
collection_date
missing